Cat Bite Vaccine For Human Rabies Virus Protection

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. is a professional China supplier providing advanced rabies prevention solutions. Cat Bite Vaccine For Human Rabies Virus Protection is developed for individuals requiring post-exposure protection after cat bites and scratches. With products supplied to more than 2000 CDC institutions and medical institutions across China, AIM Honor supports reliable rabies prevention and healthcare cooperation worldwide.

When people experience cat bites, scratches, or possible contact with rabies virus, timely prevention is essential. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides Cat Bite Vaccine For Human Rabies Virus Protection as a professional vaccine solution designed for post-exposure rabies prevention. As an experienced rabies vaccine manufacturer, AIM Honor focuses on Vero cell vaccine technology, standardized production, and reliable supply capability for healthcare organizations.

Cats are common companion animals, but injuries caused by cats should not be ignored when the animal’s vaccination status is uncertain or when exposure involves damaged skin. Rabies virus may enter the human body through wounds or mucous membrane contact, making rapid wound treatment and professional vaccination important steps after exposure.

AIM Honor provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine options. These solutions are designed to meet different medical application requirements while supporting professional rabies prevention programs.

Human Protection Needs

Cat-related injuries can happen during daily activities, pet care, animal rescue, or outdoor contact with stray cats. Although cats are usually considered low-risk animals, potential rabies exposure requires professional attention because rabies remains one of the most serious viral infectious diseases.

After exposure, the prevention process is not only about vaccination but also includes wound management, exposure evaluation, and completion of the recommended immunization schedule.

Common Exposure Situations

1. Household cat injuries: Even familiar pets may cause scratches or bites during unexpected situations. If the wound breaks the skin, professional evaluation is recommended.

2. Stray cat contact: Injuries from stray cats or unknown-status animals require greater attention because the animal health condition may be unclear.

3. Occupational exposure: Veterinarians, animal caregivers, and related professionals may face higher frequency of animal contact and require awareness of rabies prevention.

Virus Prevention Mechanism

Cat Bite Vaccine For Human Rabies Virus Protection works through immune response activation. As an inactivated rabies vaccine, it contains processed rabies virus components that cannot cause rabies but can stimulate the body to produce protective antibodies.

After vaccination, the immune system recognizes vaccine components and gradually develops an immune response. Completing the recommended vaccination schedule helps support the formation of protective antibody levels.

Protection Process

The rabies prevention process after cat exposure generally includes several important stages:

1. Exposure assessment: Healthcare professionals evaluate the wound condition, exposure category, and animal information.

2. Emergency wound treatment: The wound should be cleaned with soap water or clean water for more than 15 minutes and disinfected according to professional recommendations.

3. Vaccination completion: The complete vaccination schedule should be followed to support effective immune protection.

Technology Features

AIM Honor develops rabies vaccine products based on Vero cell culture technology. The company provides different technical solutions, including conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine, allowing customers to select suitable products according to professional requirements.

Vero Cell Vaccine Technology

Vero cell technology is an important platform used in vaccine manufacturing. AIM Honor applies this technology in rabies vaccine production to provide products focusing on immunogenicity, safety, and manufacturing consistency.

According to the provided product information, the conventional vaccine uses the indigenous aG strain, while the serum-free vaccine uses the PV-2061 strain. Both products are designed to support rabies prevention after possible exposure.

The provided product data shows that the seroconversion rate reaches 100% at 14 days after vaccination, and the neutralizing antibody level exceeds the WHO protective threshold of 0.5IU/ml.

Product Specifications

For medical institutions, distributors, and professional buyers, complete product information helps support better procurement decisions. AIM Honor provides detailed technical information for its rabies vaccine solutions based on the supplied product materials.

Core Product Value

A reliable rabies prevention product requires a combination of immune performance, manufacturing control, and practical application value. AIM Honor focuses on these key factors to provide professional solutions for healthcare partners.

Immune Response Support

The vaccine products provided by AIM Honor are developed with attention to immune response performance. According to the provided product information, both vaccine solutions use rabies virus strains with high immunogenicity.

1. Antibody development: Vaccination helps stimulate the immune system to produce protective antibodies against rabies virus.

2. Standardized schedule: Following the recommended vaccination procedure helps support effective immune protection.

3. Professional application: Medical professionals evaluate exposure conditions and provide appropriate vaccination guidance.

Safety Considerations

Safety is one of the most important factors for vaccine selection. AIM Honor manages production processes according to biological product manufacturing requirements and focuses on reducing unnecessary risks during production.

1. Conventional vaccine control: No preservatives are added, and residual bovine serum albumin is controlled at ≤10ng per dose according to the provided product information.

2. Serum-free technology: The serum-free vaccine adopts a serum-free culture process throughout production, reducing risks associated with bovine serum.

3. User experience: According to the provided information, the main adverse reaction is mild local pain, which usually resolves within 1-3 days.

Quality Management

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. emphasizes quality management throughout vaccine development, manufacturing, and supply. The company combines pharmaceutical production experience with professional technical capability to provide stable rabies prevention solutions.

Production Reliability

The company applies standardized production procedures and quality control methods for biological products. Through continuous improvement of manufacturing systems, AIM Honor supports reliable vaccine supply for healthcare institutions and professional partners.

According to the provided company information, the conventional rabies vaccine has obtained National Drug Approval Number S20073014 and maintained a 100% batch release qualification rate for 17 years.

The serum-free Vero cell rabies vaccine has completed Phase III clinical trials, and the marketing authorization application has been accepted by the Center for Drug Evaluation (CDE). The production process complies with WHO Specifications for the Use of Biological Products Raw Materials.

Procurement Advantages

For international buyers, choosing a rabies vaccine partner requires consideration of product quality, supply experience, and cooperation capability. AIM Honor provides professional support for customers requiring stable rabies prevention products.

Why Select AIM Honor

1. Manufacturing experience: AIM Honor focuses on biological pharmaceutical production and rabies vaccine solutions.

2. Supply capability: The company’s products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China.

3. Product options: Customers can select conventional Vero cell vaccine or serum-free Vero cell vaccine according to different application requirements.

4. Professional cooperation: AIM Honor supports communication and cooperation with medical organizations, distributors, and healthcare partners.

Application Fields

Rabies prevention requires suitable medical solutions for different exposure environments. Cat Bite Vaccine For Human Rabies Virus Protection is designed to support post-exposure prevention needs caused by cat-related injuries and can be applied in professional healthcare settings.

From routine medical treatment to large-scale public health programs, reliable rabies vaccine supply plays an important role in protecting individuals after possible exposure.

1. Medical institutions: Hospitals, clinics, and vaccination centers can provide professional rabies prevention services for people exposed to cat bites and scratches.

2. Disease control organizations: CDC institutions can use standardized vaccine products to support rabies prevention and control programs.

3. Animal-related industries: Veterinary workers, animal care personnel, and professionals with frequent animal contact may require professional rabies prevention awareness.

4. Public emergency situations: Individuals exposed to stray cats or unknown-status animals can receive medical evaluation and follow recommended prevention procedures.

AIM Honor Strength

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on vaccine research, development, manufacturing, and supply. The company is committed to providing professional biological product solutions through continuous technology improvement and strict quality management.

Professional Manufacturing Capability

AIM Honor has established professional vaccine production systems and focuses on improving product quality, manufacturing efficiency, and cooperation capability. The company provides both conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine solutions.

The company’s experience in rabies vaccine production allows it to support different customers, including medical institutions, distributors, and healthcare organizations requiring stable vaccine solutions.

Reliable Supply Experience

According to the provided company information, AIM Honor vaccine products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China.

This practical supply experience demonstrates the company’s ability to support professional vaccine applications and long-term cooperation requirements.

Cooperation Support

AIM Honor provides more than vaccine products. The company focuses on building long-term cooperation with customers through professional communication, product support, and stable supply services.

For buyers searching for Cat Bite Vaccine For Human Rabies Virus Protection, AIM Honor provides cooperation support based on pharmaceutical experience and vaccine manufacturing capability.

1. Product consultation: Provide professional product information and technical communication for customers.

2. Procurement support: Assist partners in understanding product characteristics and cooperation requirements.

3. Long-term cooperation: Support distributors and healthcare organizations with stable product supply solutions.

FAQ

Q: Why should people consider rabies prevention after a cat bite?

A: Cat bites and scratches may create opportunities for rabies virus exposure, especially when the animal’s health condition is unknown. After exposure, wound cleaning, medical evaluation, and vaccination according to professional recommendations are important steps for prevention.

Q: What is the role of an inactivated rabies vaccine after cat exposure?

A: An inactivated rabies vaccine helps stimulate the immune system to develop protective antibodies against rabies virus after vaccination. It is an important part of post-exposure rabies prevention procedures when recommended by healthcare professionals.

Q: How should a wound be treated immediately after a cat bite?

A: The wound should be washed with soap water or clean water for more than 15 minutes and disinfected according to professional recommendations. After first aid treatment, medical evaluation should be obtained to determine the appropriate prevention plan.

Q: What rabies vaccine products does AIM Honor provide?

A: AIM Honor provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine. Both products use Vero cell technology and are designed for rabies prevention applications.

Q: What vaccination schedule is commonly used after cat exposure?

A: According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes injections on days 0, 3, 7, 14, and 28. Healthcare professionals should determine the final schedule based on individual exposure conditions.

Q: Why choose AIM Honor as a rabies vaccine supplier?

A: AIM Honor combines vaccine manufacturing capability, professional experience, and stable supply ability. According to the provided company information, its products have been supplied to more than 2000 CDC institutions and medical institutions across China.

Final Overview

Effective rabies prevention after cat-related injuries depends on timely action, standardized vaccination procedures, and reliable vaccine supply. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides professional solutions based on Vero cell technology, pharmaceutical manufacturing experience, and quality management systems.

For healthcare organizations, distributors, and professional buyers requiring Cat Bite Vaccine For Human Rabies Virus Protection, AIM Honor offers dependable product solutions and cooperation support. Through continuous innovation and responsible manufacturing practices, the company contributes to global rabies prevention and public health protection.